Klee Justin B. (CIK 0001898314)

Latest company ownership

AMLX - Amylyx Pharmaceuticals, Inc.

Role: CEO

Shares held

3,325,301

Last filed at

Oct 2, 2025

Confidence Score

48.6

2025Q4

Confidence Score History

2023Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Sep 30, 2025	Oct 2, 2025	Amylyx Pharmaceuticals, Inc.	CEO	Sell	42.5	-29,975	-0.89%	✗	$431K
Mar 31, 2025	Apr 2, 2025	Amylyx Pharmaceuticals, Inc.	CEO	Sell	45.0	-21,490	-0.64%	✗	$74.5K
Mar 3, 2025	Mar 5, 2025	Amylyx Pharmaceuticals, Inc.	CEO	Sell	51.3	-4,595	-0.14%	✗	$14.5K
Feb 3, 2025	Feb 5, 2025	Amylyx Pharmaceuticals, Inc.	CEO	Sell	51.3	-11,855	-0.37%	✗	$41.1K
Jan 6, 2025	Jan 8, 2025	Amylyx Pharmaceuticals, Inc.	CEO	Sell	51.3	-7,471	-0.23%	✗	$30.2K
Sep 30, 2024	Oct 2, 2024	Amylyx Pharmaceuticals, Inc.	CEO	Sell	45.0	-18,589	-0.59%	✗	$59.4K
Mar 5, 2024	Mar 7, 2024	Amylyx Pharmaceuticals, Inc.	CEO	Sell	47.5	-4,135	-0.14%	✗	$77.4K
Jan 9, 2024	Jan 11, 2024	Amylyx Pharmaceuticals, Inc.	CEO	Sell	47.5	-5,841	-0.21%	✗	$95.4K
Mar 16, 2023	Mar 20, 2023	Amylyx Pharmaceuticals, Inc.	CEO	Sell	40.0	-50,000	-1.73%	✓	$3.2M
Jan 6, 2023	Jan 10, 2023	Amylyx Pharmaceuticals, Inc.	CEO	Buy	60.0	+5,968	0.10%	✓	$216.6K